Valeant Slides After Drugmaker Cuts 2016 Profit Forecast: Chart

Valeant Falls After Cutting Profit Forecast

Shares of Valeant Pharmaceuticals International Inc. fell in early trading after the embattled drugmaker cut its 2016 profit forecast. Earnings will be $6.60 to $7 a share, excluding some items, the company said in a statement Tuesday.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE